Most human cancers harbour aberrations of cell-cycle control(1), which resu
lt in deregulated activity of the E2F transcription factors with concomitan
t enhanced cell-cycle progression(2). Oncogenic signalling by E2F1 has rece
ntly been linked to stabilization and activation of the tumour suppressor p
53 (refs 1,3,4). The p73 protein shares substantial sequence homology and f
unctional similarity with p53 (refs 5-7). Hence, several previously conside
red p53-independent cellular activities may be attributable to p73. Here we
provide evidence that E2F1 directly activates transcription of TP73, leadi
ng to activation of p53-responsive target genes and apoptosis. Disruption o
f p73 function by a tumour-derived p53 mutant reduced E2F1-mediated apoptos
is. Thus, p73 activation by deregulated E2F1 activity might constitute a p5
3-independent, anti-tumorigenic safeguard mechanism.